Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer [Phase 2]
Clinical trial update noting the completion of a Phase 2 study evaluating a psychosexual intervention in patients with Stage I-III gynecolog…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients [Phase 2]
Phase 2 trial evaluating metformin for preventing relapse by targeting cancer stem cells in gynecologic cancers; results were posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
A completed clinical trial update from the Gynecologic Oncology Group examining biomarkers in patients with previously untreated invasive ov…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
A terminated clinical trial update investigating the serum biomarker YKL-40 in patients with newly diagnosed stage III-IV ovarian epithelial…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
This Phase 3 trial investigated bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, fall…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update investigating bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, f…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab [NA]
This is a completed clinical trial evaluating Polyvalent Vaccine-KLH Conjugate and Opt-821 in combination with Bevacizumab for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 1]
Phase 1 clinical trial update evaluating the p53MVA vaccine in combination with gemcitabine hydrochloride for recurrent ovarian epithelial c…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: A Study of Chemotherapy Treatment for Patients With Ovarian Cancer [Phase 2]
This completed Phase 2 clinical trial evaluated a chemotherapy treatment for ovarian cancer and related fallopian tube and primary peritonea…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A completed Gynecologic Oncology Group trial evaluated changes in brain function (cognitive side effects) in patients with stage I–IV ovaria…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [NA]
A terminated clinical trial evaluated a triple antiemetic regimen (granisetron, aprepitant, and dexamethasone) to prevent chemotherapy-induc…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for MLN8237 in ovarian, fallopian tube, or peritoneal carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or peritoneal cancer has completed recruitment wi…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 testing evaluating drug sensitivity in ovarian, fallopian tube, and…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating diet and physical activity changes versus usual care for improving progression-free survival in previously treated …
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating HIPEC as neoadjuvant chemotherapy and postoperative chemotherapy for advanced epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 clinical trial evaluating Paclitaxel and Carboplatin with or without Bevacizumab in Stage II-IV ovarian epithelial cancer, primary p…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating carboplatin/pralatrexate in recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer co…
-
CLINICAL_TRIALS trial_result · 2018-01-11Clinical Trial Update: AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of AMG 706 in persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer was termi…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating acetylcysteine with topotecan hydrochloride in patients with persistent or recurrent high-grade ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) for periton…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating intraperitoneal natural killer cells in combination with INCB024360 for recurrent ovarian, fallopian tube, and pr…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) [Phase 3]
The Phase 3 TRINOVA-2 trial of trebananib (AMG 386) in fallopian tube cancer, ovarian cancer, and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]
Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked a…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.